Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer

Tsui F. Cheng, Jung D. Wang, Wu C. Uen

Research output: Contribution to journalArticle

9 Citations (Scopus)

Fingerprint Dive into the research topics of 'Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences